About Lindis Blood Care
Lindis Blood Care is a company based in Hennigsdorf (Germany) founded in 2006 by Franzpeter Bracht and Horst Lindhofer. It operates as a HealthTech. Lindis Blood Care has raised $1.89 million across 3 funding rounds from investors including Investitionsbank des Landes Brandenburg, Brandenburg Capital and High-Tech Gründerfonds. Lindis Blood Care offers products and services including CATUVAB®. Lindis Blood Care operates in a competitive market with competitors including Hemotune, On Target Laboratories, Huake Precision (Beijing) Medical Technology, Averto Medical and Medcura, among others.
- Headquarter Hennigsdorf, Germany
- Founders Franzpeter Bracht, Horst Lindhofer
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lindis Blood Care Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.89 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lindis Blood Care
Lindis Blood Care offers a comprehensive portfolio of products and services, including CATUVAB®.
Device removes tumor cells for safer blood transfusions.
People of Lindis Blood Care
Unlock access to complete
Unlock access to complete
Funding Insights of Lindis Blood Care
Lindis Blood Care has successfully raised a total of $1.89M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lindis Blood Care
Lindis Blood Care has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Investitionsbank des Landes Brandenburg, Brandenburg Capital and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by Brandenburg Capital toward multiple sectors.
|
Locked | Locked | Locked | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
Financial support and programs are provided for businesses and housing.
|
Locked | Locked | Locked |
Investor details for Lindis Blood Care
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lindis Blood Care
Investment portfolio details for Lindis Blood Care
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lindis Blood Care
Detailed financials for Lindis Blood Care
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lindis Blood Care Comparisons
Peer comparison for Lindis Blood Care
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lindis Blood Care
Lindis Blood Care operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, On Target Laboratories, Huake Precision (Beijing) Medical Technology, Averto Medical and Medcura, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a device for blood purification
|
|
| Locked | Locked | Locked |
Molecular imaging agents for cancer surgery are developed.
|
|
| Locked | Locked | Locked |
Neurosurgery robots are provided for neurological disorder treatments.
|
|
| Locked | Locked | Locked |
Medical devices for gastrointestinal disease patients are developed.
|
|
| Locked | Locked | Locked |
Developer of the device for controlling bleeding
|
|
| Locked | Locked | Locked |
Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking
|
Detailed competitors of Lindis Blood Care
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lindis Blood Care
Complete news archive for Lindis Blood Care
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lindis Blood Care
Lindis Blood Care was founded in 2006 and raised its 1st funding round 13 years after it was founded.
Lindis Blood Care is headquartered in Hennigsdorf, Germany. It is registered at Hennigsdorf, Brandenburg, Germany.
Lindis Blood Care is a funded company, having raised a total of $1.89M across 3 funding rounds to date.
Solutions for safer blood transfusions are provided by Lindis Blood Care. Focus is placed on removing tumor and immune cells from blood during cancer surgeries using proprietary ABCR-Technology. The flagship product, CATUVAB, enables safe autologous blood retransfusion, reducing reliance on donor blood. Expansion into markets like EU, US, and Asia is planned. Strategic partnerships for distribution and licensing are sought in various regions. Patient outcomes in oncological surgeries are improved through this technology.
Lindis Blood Care's top competitors include Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics and Medcura.
Lindis Blood Care offers CATUVAB®.
Lindis Blood Care has 3 investors. Key investors include Investitionsbank des Landes Brandenburg, Brandenburg Capital, and High-Tech Gründerfonds.